The biology of breast cancer

Hematology/Oncology Clinics of North America

Volumn 13, Issue 2, 1999, Pages 311-332

  Nass, S J ^a   Davidson, N E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ANDROGEN; ANTIESTROGEN; EPIDERMAL GROWTH FACTOR; ESTROGEN; FIBROBLAST GROWTH FACTOR; GLUCOCORTICOID; GROWTH FACTOR; GROWTH HORMONE; HORMONE; INHIBIN; OXYTOCIN; PEPTIDE HORMONE; PROGESTERONE; PROLACTIN; SOMATOMEDIN; SOMATOSTATIN; TAMOXIFEN; THYROID HORMONE; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CELL SURVIVAL; HORMONAL REGULATION; HORMONE ACTION; PRIORITY JOURNAL; REVIEW;

EID: 0032987987     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70058-7     Document Type: Article

References (123)

1. J.C. Allegra M.E. Lippman R. Simon Association between steroid hormone receptor status and disease-free interval in breast cancer Cancer Treatment Reports 63 1979 1271
2. L.T. Amundadottir S.J. Nass G. Berchem Cooperation of TGFα and c-Myc in mouse mammary tumorigenesis: Coordinated stimulation of growth and suppression of apoptosis Oncogene 13 1996 757
3. D.K. Armstrong J.T. Isaacs Y.L. Ottaviano Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468 Cancer Res 52 1992 3418
4. D.K. Armstrong S.H. Kaufmann Y.L. Ottaviano Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells Cancer Res 54 1994 5280
5. C.L. Arteaga S.D. Hurd A.R. Winnier Anti-transforming growth factor beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity J Clin Invest 92 1993 2569
6. P. Bates R. Fisher A. Ward Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGFII) Br J Cancer 72 1995 1189
7. M.W. Beckmann D. Niederacher H.G. Schnurch Multistep carcinogenesis of breast cancer and tumour heterogeneity J Mol Med 75 1997 429
8. M. Ben-Jonathan J.L. Mershon D.L. Allen Extrapituitary prolactin: Distribution, regulation, functions, and clinical aspects Endocr Rev 17 1996 639
9. D. Bertwistle A. Ashworth Functions of the BRCA1 and BRCA2 genes Curr Opin Genet Dev 8 1998 14
10. A.P. Bird CpG-rich islands and the function of DNA methylation Nature 321 1986 209
11. F. Borellini T. Oka Growth control and differentiation in mammary epithelial cells Environ Health Perspect 80 1989 85
12. C. Brisken S. Park T. Vass A paracrine role for the epithelial progesterone receptor in mammary gland development Dev Biol 95 1998 5076
13. H. Cedar DNA methylation and gene activity Cell 53 1988 3
14. C.V. Clevenger W.P. Chang W. Ng Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop Am J Pathol 146 1995 695
15. M.A. Cobleigh C.L. Vogel D. Tripathy Efficacy and safety of Herceptin (humanized anti-HER2 antibody) as a single agent in 222 women with HER2 overexpression who relapsed following chemotherapy for metastatic breast cancer [abstract 376] Proceedings of the American Society of Clinical Oncology 17 1998 97a
16. G.A. Colditz Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer J Natl Cancer Inst 90 1998 814
17. R. Colomer J. Aparicio S. Montero Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma Br J Cancer 76 1997 1215
18. S.R. Cummings L. Norton S. Eckert Raloxifene reduces the risk of breast cancer and may decrease the risk of endometrial cancer in post-menopausal women. Two-year findings from the multiple outcomes of raloxifene evaluations (MORE) trial [abstract 3] Proceedings of the American Society of Clinical Oncology 17 1998 2a
19. I. d'Agnano B. Bucci M. Mottolese DNA ploidy, cell kinetics, and epidermal growth factor receptor and HER2/neu oncoprotein expression in primary operable breast cancer Ann N Y Acad Sci 784 1996 472
20. C.W. Daniel G.B. Silberstein K. Van Horn TGF-β1-induced inhibition of mouse mammary ductal growth: Developmental specificity and characterization Dev Biol 135 1989 20
21. R.B. Dickson M.E. Lippman Growth factors in breast cancer Endocr Rev 16 1995 559
22. R.B. Dickson M.E. Lippman Growth regulation of normal and malignant breast epithelium ed 2 K.I. Bland E.M. Copeland III The Breast: Comprehensive Management of Benign and Malignant Diseases vol 1 1998 WB Saunders Philadelphia 518
23. J.O. Drife Breast development in puberty Ann N Y Acad Sci 464 1986 58
24. Early Breast Cancer Trialists Collaborative Group Tamoxifen for early breast cancer: An overview of the randomized trials Lancet 351 1998 1451
25. H.S. Earp T.L. Dawson X. Li Heterodimerization and functional interaction between EGF receptor family members: A new signaling paradigm with implication for breast cancer research Breast Cancer Res Treat 35 1995 115
26. T.J. Eberlein P. Goedegebuure Immunology and the role of immunotherapy in breast cancer ed 2 K.I. Bland E.M. Copeland III The Breast: Comprehensive Management of Benign and Malignant Diseases vol 1 1998 WB Saunders Philadelphia 605
27. L.M. Ellis G.L. Nicolson I.J. Fidler Concepts and mechanisms of breast cancer metastasis ed 2 K.I. Bland E.M. Copeland III The Breast: Comprehensive Management of Benign and Malignant Diseases vol 1 1998 WB Saunders Philadelphia 564
28. J. Enenstein N.S. Waleh R.H. Kramer Basic FGF and TGF-β differentially modulate integrin expression of human microvascular endothelial cells Exp Cell Res 203 1992 499
29. Z. Feng A. Marti B. Jehn Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland J Cell Biol 131 1995 1095
30. A.T. Ferguson N.E. Davidson Regulation of estrogen receptor α function in breast cancer Crit Rev Oncog 8 1997 29
31. A.T. Ferguson R.G. Lapidus S.B. Baylin Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression Cancer Res 55 1995 2279
32. P.A. Fernandes Prolactin physiology in the etiology of breast cancer Seminars in Reproductive Endocrinology 10 1992 258
33. B. Fisher C. Redmond E.R. Fisher Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: Findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06 J Clin Oncol 6 1988 1076
34. J. Folkman Angiogenesis in breast cancer ed 2 K.I. Bland E.M. Copeland III The Breast: Comprehensive Management of Benign and Malignant Diseases vol 1 1998 WB Saunders Philadelphia 586
35. G. Fuh J.A. Wells Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines J Biol Chem 270 1995 13133
36. M. Garcia D. Derocq G. Freiss Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells Proc Natl Acad Sci USA 89 1992 11538
37. E. Ginsberg B.K. Vonderhaar Prolactin synthesis and secretion by human breast cancer cells Cancer Res 55 1995 2591
38. V. Goffin P.A. Kelly Prolactin and growth hormone receptors Clin Endocrinol 45 1996 247
39. 1 associates with disease progression in human breast cancer Cancer Res 52 1992 6949
40. S.E. Hankinson W.C. Willett G.A. Colditz Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer Lancet 351 1998 1393
41. B.E. Henderson R. Ross L. Bernstein Estrogens as a cause of human cancer: The Richard and Hinda Rosenthal Foundation Award lecture Cancer Res 48 1988 246
42. M.E. Herman B.S. Katzenellenbogen Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth Cancer Res 54 1994 5867
43. W. Imagawa G.K. Bandyopadhyay S. Nandi Regulation of mammary epithelial cell growth in mice and rats Endocr Rev 11 1990 494
44. C. Jhappan A.G. Geiser E.C. Kordon Targeting expression of a transforming growth factor β1 transgene to the pregnant mammary gland inhibits alveolar development and lactation EMBO J 12 1993 1835
45. S.-Y. Jiang V.C. Jordan Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor J Natl Cancer Inst 84 1992 580
46. V.C. Jordan J.E. Glusman S. Eckert Incident primary breast cancers are reduced by raloxifene: Integrated data from multicenter, double-blind, randomized trials in ∼12,000 postmenopausal women [abstract 466] Proceedings of the American Society of Clinical Oncology 17 1998 122a
47. F.G. Kern S.W. McLeskey L. Zhang Transfected MCF-7 cells as a model for breast cancer progression Breast Cancer Res Treat 31 1994 153
48. D.L. Kleinberg Role of IGF-1 in normal mammary development Breast Cancer Res Treat 47 1998 201
49. D.L. Kleinberg W. Ruan V. Catanese Non-lactogeneic effects of growth hormone on growth and IGF1 mRNA of rat mammary gland Endocrinology 126 1990 3274
50. W.A. Knight III R.B. Livingston E.J. Gregory Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer Cancer Res 37 1977 4669
51. K.S. Korach Insights from the study of animals lacking functional estrogen receptor Science 266 1994 1524 1527
52. G.G.J.M. Kuiper E. Enmark M. Pelto-Huikko Cloning of a novel estrogen receptor in rat prostate and ovary Proc Natl Acad Sci USA 93 1996 5925
53. R. Kumar M. Mandal A. Lipton Overexpression of Her2 modulates Bcl-2, Bcl-x(L), and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells Clinical Cancer Research 2 1996 1215
54. T. Kuukasjarvi J. Kononen K. Helin Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy J Clin Oncol 14 1996 2584
55. N. Kyprianou H.F. English N.E. Davidson Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation Cancer Res 51 1991 162
56. P.W. Laird R. Jaenisch The role of DNA methylation in cancer genetics and epigenetics Annu Rev Genet 30 1996 441
57. R.G. Lapidus S.J. Nass N.E. Davidson The loss of estrogen and progesterone receptor gene expression in human breast cancer Journal of Mammary Gland Biology and Neoplasia 3 1998 85
58. R.G. Lapidus S.J. Nass K.A. Butash Mapping of the ER gene CpG island methylation by methylation specific PCR Cancer Res 58 1998 2515
59. R.G. Lapidus A.T. Ferguson Y.L. Ottaviano Methylation of estrogen and progesterone receptor gene 5′ CpG island correlates with lack of estrogen and progesterone receptor gene expression in breast tumors Clinical Cancer Research 2 1996 805
60. A.V. Lee S.G. Hilsenbeck D. Yee IGF system components as prognostic markers in breast cancer Breast Cancer Res Treat 47 1998 295
61. C.K.H. Leung R.P.C. Shiu Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice Cancer Res 41 1981 546
62. E. Li C. Beard R. Jaenisch Role for DNA methylation in genomic imprinting Nature 366 1993 362
63. W.L. McGuire Hormone receptors: Their role in predicting prognosis and response to endocrine therapy Semin Oncol 5 1979 428
64. S.W. McLeskey L. Zhang D. El-Ashry Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatiase inhibitors Clinical Cancer Research 4 1998 697
65. G. Merlo F. Basolo L. Fiore p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin J Cell Biol 128 1995 1185
66. H.C. Mertani T. Garcia-Caballero A. Lambert Cellular expression of growth hormone and prolactin receptors in human breast disorders Int J Cancer 79 1998 202
67. H. Michna K.-H. Fritzemeier K. Parczyk Antiprogestin-progesterone interactions R.B. Dickson Lippman M.E. Mammary Tumor Cell Cycle, Differentiation and Metastasis 1996 Kluwer Academic Publishers Boston 191
68. H. Michna S. Gehring W. Kuhnel The antitumor potency of progesterone antagonists is due to their differentiation potential J Steroid Biochem Mol Biol 43 1992 203
69. H. Michna Y. Nishino G. Neef Progesterone antagonists: Tumor-inhibiting potential and mechanism of action J Steroid Biochem Mol Biol 41 1992 339
70. Miller DL, el-Ashry D, Cheville AL, et al: Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: Evidence for a role of EGFR in breast cancer growth and progression. 5:1263, 1994
71. J.A. Mol S.C. Henzen-Longmans P. Hageman Expression of the gene encoding growth hormone in the human mammary gland J Clin Endocrinol Metab 80 1995 3094
72. J.A. Mol E. van Garderen G.R. Rutteman New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: Induction of the local biosynthesis of growth hormone (GH) in the mammary glands of dogs, cats and humans J Steroid Biochem Mol Biol 57 1996 67
73. S.J. Nass R.B. Dickson Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells which overexpress c-myc Clinical Cancer Research 4 1998 1813
74. S.J. Nass R.B. Dickson Defining a role for c-Myc in breast tumorigenesis Breast Cancer Res Treat 44 1997 1
75. L in the regulation of apoptosis by EGF and TGFβ1 in c-Myc overexpressing mammary epithelial cells Biochem Biophys Res Commun 227 1996 248
76. S. Neuenschwander A. Schwartz T.L. Wood Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model J Clin Invest 97 1996 2225
77. J.C. Newby S.R.D. Johnston I.E. Smith Expression of epidermal growth factor receptor and c-ErbB2 during the development of tamoxifen resistance in human breast cancer Clinical Cancer Research 3 1997 1643
78. S.T. Ng J. Zhou O.O. Adesanyz Growth hormone treatment induces mammary gland hyperplasia in aging primates Nat Med 3 1997 1081
79. A.J. Oates L.M. Schumaker S.B. Jenkins The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGFR), a putative breast tumor suppressor gene Breast Cancer Res Treat 47 1998 269
80. Y. Oh IGF-independent regulation of breast cancer growth by IGF binding proteins Breast Cancer Res Treat 47 1998 283
81. G. Ong K. Sikora W.J. Gullick Inactivation of the retinoblastoma gene does not lead to loss of TGF-beta receptors or response to TGF-beta in breast cancer cell lines Oncogene 6 1991 761
82. C.J. Ormandy A. Camus J. Barra Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse Genes Dev 11 1997 167
83. C.J. Ormandy R.E. Hall D.L. Manning Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer J Clin Endocrinol Metab 82 1997 3692
84. C.K. Osborne D.H. Boldt G.M. Clark Effects of tamoxifen on human breast cancer cell cycle kinetics Cancer Res 43 1983 3583
85. Y.L. Ottaviano J.P. Issa F.F. Parl Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells Cancer Res 54 1994 2552
86. M.F. Pichon P. Broet H. Magdelenat Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers Br J Cancer 73 1996 1545
87. D.F.J. Pierce A.E. Gorska A. Chytil Mammary tumor suppression by transforming growth factor beta transgene expression Proc Natl Acad Sci USA 92 1995 4254
88. R.J. Pietras J. Arboleda D.M. Reese HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells Oncogene 10 1995 2435
89. M.N. Pollak Endocrine effects of IGF-1 on normal and transformed breast epithelial cells: Potential relevance to strategies for breast cancer treatment and prevention Breast Cancer Res Treat 47 1998 209
90. A.A. Rasmussen K.J. Cullen Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors Breast Cancer Res Treat 47 1998 219
91. L.D. Read C.E. Snider J.S. Miller Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines Mol Endocrinol 2 1988 263
92. J.C. Reed Balancing cell life and death: Bax, apoptosis, and breast cancer J Clin Invest 97 1996 2403
93. M. Reiss M.H. Barcellos-Hoff Transforming growth factor β in breast cancer: A working hypothesis Breast Cancer Res Treat 45 1997 81
94. C. Reynolds K.T. Montone C.M. Powell Expression of prolactin and its receptor in human breast carcinoma Endocrinology 138 1997 5555
95. A. Rijnberk J.A. Mol Progestin-induced hypersecretion of growth hormone: An introductory review J Reprod Fertil S51 1997 335
96. S.D. Robinson G.B. Silberstein A.B. Roberts Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development Development 113 1991 867
97. 1 (Ser223–225) EMBO J 11 1992 1599
98. E.P. Sandgren J.A. Schroeder T.H. Qui Inhibition of mammary gland involution is associated with TGFα- but not c-myc-induced tumorigenesis in transgenic mice Cancer Res 55 1995 3915
99. Y.E. Shi Y.E. Liu M.E. Lippman Progestins and antiprogestins in mammary tumour growth and metastasis H.M. Beier I.M. Spitz Progesterone Antagonists in Reproductive Medicine and Oncology 1994 Oxford University Press Oxford 162 Human Reprod 9(Suppl 1)
100. G.B. Silberstein C.W. Daniel Reversible inhibition of mammary gland growth by transforming growth factor-β Science 237 1987 291
101. J.M. Slingerland L. Hengst C.H. Pan A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells Mol Cell Biol 14 1994 3683
102. G.D. Smith R. Sharp E.C. Kordon Transforming growth factor α promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells Am J Pathol 147 1995 1081
103. M. Stampfer J. Garbe C. Pan TGFβ effects on cell cycle progression of normal and immortal human mammary epithelial cells in culture J Cell Biochem Suppl 19A 1995 77
104. R. Strange F. Li S. Saurer Apoptoic cell death and tissue remodelling during mouse mammary gland involution Development 115 1992 49
105. E. Surmacz M.A. Guvakova M.K. Nolan Type I insulin-like growth factor receptor function in breast cancer Breast Cancer Res Treat 47 1998 255
106. K.J.E. Sweeney E.A. Musgrove C.K.W. Watts Cyclins and breast cancer R.B. Dickson M.E. Lippman Mammary Tumor Cell Cycle, Differentiation and Metastasis 1996 Kluwer Academic Publishers Boston 141
107. C. Teixeira J.C. Reed M.A.C. Pratt Estrogen promotes chemotherapeutic drug resistance by a mechanism involving bcl-2 proto-oncogene expression in human breast cancer cells Cancer Res 55 1995 3902
108. J. Tornell L. Rymo O.G.P. Isaksson Induction of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice Int J Cancer 49 1991 114
109. M.T. Travers P.J. Barrett-Lee U. Berger Growth factor expression in normal, benign, and malignant breast tissue BMJ 296 1988 1621
110. E.M. Valverius D. Walker-Jones S.E. Bates Production of and responsiveness to transforming growth factor-β in normal and oncogene-transformed human mammary epithelial cells Cancer Res 49 1989 6269
111. E. van Garderen M. deWit W.F. Voorhout Expression of growth hormone in canine mammary tissue and mammary tumors. Evidence for a potential autocrine/paracrine stimulatory loop Am J Pathol 150 1997 1037
112. E. Vladusic A. Hornby F.K. Guerra-Vladusic Expression of estrogen receptor β messenger RNA variant in breast cancer Cancer Res 58 1998 210
113. H. Wang M. Rubin E. Fenig Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events Cancer Res 57 1997 1750
114. Q. Wang P. Maloof H. Wang Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells Experimental Cell Research 238 1998 177
115. T.T.Y. Wang J.M. Phang Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7 Cancer Res 55 1995 2487
116. C.W. Welsch H. Nagasawa Prolactin and murine mammary tumorigenesis: A review Cancer Res 37 1977 951
117. D.L. Wickerham J.C. Costantino B. Fisher The initial results from NSABP protocol P-1: A clinical trial to determine the worth of tamoxifen for preventing breast cancer in women at increased risk [abstract 3] Proceedings of the American Society of Clinical Oncology 17 1998 2a
118. C. Yiangou J.J. Gomm R.C. Coope Fibroblast growth factor 2 in breast cancer: Occurrence and prognostic significance Br J Cancer 75 1997 28
119. D.A. Zajchowski R. Sager L. Webster Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor Cancer Res 53 1993 5004
120. L. Zhang S. Kharbanda D. Chen MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice Oncogene 15 1997 2093
121. L. Zhang S. Kharbanda J. Hanfelt Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells Cancer Res 58 1998 352
122. G. Zugmaier B.W. Ennis B. Deschauer Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell lines J Cell Physiol 141 1989 353
123. G. Zugmaier S. Paik G. Wilding Transforming growth factor β1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice Cancer Res 51 1991 3590